Works by Robbins, Paul F.
Results: 20
Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: Implications as a potential biomarker.
- Published in:
- International Journal of Cancer, 2005, v. 114, n. 2, p. 268, doi. 10.1002/ijc.20716
- By:
- Publication type:
- Article
A listing of human tumor antigens recognized by T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 1, p. 3, doi. 10.1007/s002620000169
- By:
- Publication type:
- Article
Longitudinal Study of Recurrent Metastatic Melanoma Cell Lines Underscores the Individuality of Cancer Biology.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 5, p. 1389, doi. 10.1038/jid.2013.495
- By:
- Publication type:
- Article
Clonal Persistence and Evolution During a Decade of Recurrent Melanoma.
- Published in:
- Journal of Investigative Dermatology, 2006, v. 126, n. 6, p. 1372, doi. 10.1038/sj.jid.5700193
- By:
- Publication type:
- Article
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08304-z
- By:
- Publication type:
- Article
MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells.
- Published in:
- Cancer Gene Therapy, 2002, v. 9, n. 11, p. 946, doi. 10.1038/sj.cgt.7700509
- By:
- Publication type:
- Article
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 3, p. 620, doi. 10.1038/mt.2010.272
- By:
- Publication type:
- Article
Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas.
- Published in:
- International Journal of Cancer, 1993, v. 53, n. 6, p. 892, doi. 10.1002/ijc.2910530604
- By:
- Publication type:
- Article
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells.
- Published in:
- Nature Medicine, 2013, v. 19, n. 6, p. 747, doi. 10.1038/nm.3161
- By:
- Publication type:
- Article
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.
- Published in:
- European Journal of Immunology, 2003, v. 33, n. 7, p. 2033, doi. 10.1002/eji.200323909
- By:
- Publication type:
- Article
N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 9, p. 2690, doi. 10.1002/1521-4141(200109)31:9<2690::AID-IMMU2690>3.0.CO;2-8
- By:
- Publication type:
- Article
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumors.
- Published in:
- 2014
- By:
- Publication type:
- journal article
PD-1 identifies the patient-specific CD8<sup>+</sup> tumor-reactive repertoire infiltrating human tumors.
- Published in:
- Journal of Clinical Investigation, 2014, v. 124, n. 5, p. 2246, doi. 10.1172/JCI73639
- By:
- Publication type:
- Article
Tumor-infiltrating human CD4<sup>+</sup> regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity.
- Published in:
- Science Immunology, 2019, v. 4, n. 31, p. 1, doi. 10.1126/sciimmunol.aao4310
- By:
- Publication type:
- Article
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 3, p. 383, doi. 10.1007/s00262-008-0562-x
- By:
- Publication type:
- Article
Targeting neoantigens for cancer immunotherapy.
- Published in:
- International Immunology, 2016, v. 28, n. 7, p. 365, doi. 10.1093/intimm/dxw026
- By:
- Publication type:
- Article